Tue, Jul 29, 2014, 9:18 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

The Blackstone Group L.P. Message Board

sam_0534 188 posts  |  Last Activity: 25 minutes ago Member since: Feb 8, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    IPCI chart info.. 50 dma is 4.10, 100 dma is 3.97

    by sam_0534 May 19, 2014 7:55 PM
    sam_0534 sam_0534 May 19, 2014 7:56 PM Flag

    alays need good volume for breakout of the 50 dma

    Sentiment: Strong Buy

  • stocastics in the very oversold region.. best to buy when this happens...http://finance.yahoo.com/q/ta?t=1y&l=on&z=l&q=b&p=m50%2Cm100%2Cm200%2Cv&a=m26-12-9%2Cr14%2Css&c=&s=ipci&ql=1

    Sentiment: Strong Buy

  • sam_0534 sam_0534 May 14, 2014 1:55 PM Flag

    it seems to me that BX should be buying its own stock...sont know why they dont??

    Sentiment: Strong Buy

  • Stock Market & Financial Investment News

    News Breaks
    May 14, 2014
    04:55 EDT BX, BX Blackstone management to meet with Oppenheimer
    Meeting to be held in New York on May 19 hosted by Oppenheimer.
    News For BX From The Last 14 Days

    Sentiment: Strong Buy

  • http://www.bloomberg.com/video/blackstone-takes-advantage-of-ipo-windows-qEjTJGuYSriq9t6u1cc77w.html?cmpid=yhoo

    Sentiment: Strong Buy

  • sam_0534 by sam_0534 May 13, 2014 8:30 PM Flag

    well the stocastics turned up from deeply oversold levels....and it bounced off the 200 dma..a major support point.. major resistance is at the 50 dma of 31.62 and the 100 dma of 31.33.......http://finance.yahoo.com/q/ta?s=BX&t=1y&l=on&z=l&q=b&p=m50%2Cm100%2Cm200&a=m26-12-9%2Cr14%2Css%2Cv&c=

    Sentiment: Buy

  • News Breaks
    May 13, 2014
    14:41 EDT ACT, QCOR, MNK FDA approval of generic Exalgo negative for Mallinckrodt, says BMO Capital
    BMO Capital thinks the FDA's approval of Actavis’ (ACT) generic version of Exalgo was expected, but the firm still views it as a near-term negative for Mallinckrodt (MNK). BMO expects Mallinckrodt's raised guidance and pending accretive Questcor (QCOR) deal to support the stock longer-term and maintains an Outperform rating on Mallinckrodt.

  • sam_0534 by sam_0534 May 13, 2014 3:03 PM Flag

    News Breaks
    May 13, 2014
    14:41 EDT ACT, QCOR, MNK FDA approval of generic Exalgo negative for Mallinckrodt, says BMO Capital
    BMO Capital thinks the FDA's approval of Actavis’ (ACT) generic version of Exalgo was expected, but the firm still views it as a near-term negative for Mallinckrodt (MNK). BMO expects Mallinckrodt's raised guidance and pending accretive Questcor (QCOR) deal to support the stock longer-term and maintains an Outperform rating on Mallinckrodt.

  • http://www.thestreet.com/_yahoo/video/12706936/in-private-equity-land-its-good-to-be-blackstone-group.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NA&s=1

    Sentiment: Strong Buy

  • sam_0534 by sam_0534 May 12, 2014 8:23 PM Flag

    brought public at 20

  • Blackstone Quadruples Pinnacle Investment With $6.6 Billion Sale
    By David Carey May 12, 2014 8:47 AM PT 0 Comments Email Print
    Facebook
    Twitter
    Google+
    LinkedIn
    Save
    Blackstone Group LP (BX) will score about a 300 percent partly realized gain on Pinnacle Foods Inc.’s (PF) $6.6 billion sale to Hillshire Brands Co., as private equity firms capitalize on a surge in asset values to unload holdings.

    The world’s biggest manager of alternative assets, which owns 51 percent of Pinnacle, will receive $1.1 billion for its Pinnacle shares and Hillshire stock valued at $1.1 billion, based on Hillshire’s closing price Friday of $36.95. It aquired the foodmaker for $2.2 billion seven years ago using a combination of equity and debt.

    The sale adds to a series of exits that helped Blackstone return $11.5 billion to investors in its private-equity, real estate and hedge funds last quarter. The New York-based firm, which manages $272 billion, reported last month that its first-quarter profit rose 30 percent as the carrying value of its holdings invested and it collected more fees.

    Blackstone originally invested $414.2 million of equity in a leveraged buyout of Parsippany, N.J.-based Pinnacle. The sellers were the private-equity arm of JPMorgan Chase & Co. and JW Childs Associates LP, a Boston-based buyout firm.

    Blackstone boosted its investment by $260 million to $674.2 million when Pinnacle acquired Birds Eye Foods LLC in 2010. It sold a fraction of its Pinnacle shares in December for $503.3 million and has taken at least $53.8 million in dividends from Pinnacle, which owns the Birds Eye, Duncan Hines and Vlasic food brands, according to regulatory filings.

  • Blackstone Quadruples Pinnacle Investment With $6.6 Billion Sale
    By David Carey May 12, 2014 8:47 AM PT 0 Comments Email Print
    Facebook
    Twitter
    Google+
    LinkedIn
    Save
    Blackstone Group LP (BX) will score about a 300 percent partly realized gain on Pinnacle Foods Inc.’s (PF) $6.6 billion sale to Hillshire Brands Co., as private equity firms capitalize on a surge in asset values to unload holdings.

    The world’s biggest manager of alternative assets, which owns 51 percent of Pinnacle, will receive $1.1 billion for its Pinnacle shares and Hillshire stock valued at $1.1 billion, based on Hillshire’s closing price Friday of $36.95. It aquired the foodmaker for $2.2 billion seven years ago using a combination of equity and debt.

    The sale adds to a series of exits that helped Blackstone return $11.5 billion to investors in its private-equity, real estate and hedge funds last quarter. The New York-based firm, which manages $272 billion, reported last month that its first-quarter profit rose 30 percent as the carrying value of its holdings invested and it collected more fees.

    Blackstone originally invested $414.2 million of equity in a leveraged buyout of Parsippany, N.J.-based Pinnacle. The sellers were the private-equity arm of JPMorgan Chase & Co. and JW Childs Associates LP, a Boston-based buyout firm.

    Blackstone boosted its investment by $260 million to $674.2 million when Pinnacle acquired Birds Eye Foods LLC in 2010. It sold a fraction of its Pinnacle shares in December for $503.3 million and has taken at least $53.8 million in dividends from Pinnacle, which owns the Birds Eye, Duncan Hines and Vlasic food brands, according to regulatory filings.

    Peter Rose, a Blackstone spokesman, declined to co

  • doesnt make sense...

    Sentiment: Buy

  • View photo
    Adam Jeffery | CNBC

    The U.S. should make it harder for companies to reap tax benefits from merging with foreign corporations, former Treasury Secretary Tim Geithner said in a wide-ranging interview on CNBC that aired Monday.

    The recent debate over these tax-driven deals kicked into high gear with Pfizer (PFE)'s $106 billion offer to buy its British rival AstraZeneca (London Stock Exchange: AZN-GB). If completed, the American drug company could save billions of dollars by relocating to the U.K., where business taxes are lower.

    Geithner said in the interview on " Squawk Box " the foreign merger situation showed the need for the Obama administration's 2012 corporate tax reform plan, which failed to win support. "It was to address, partly, this risk [and] to try to create a system where there's better incentives for investment."

    Under the plan unveiled in February 2012, the White House proposed eliminating tax loopholes and lowering the corporate tax rate from 35 percent to 28 percent. It had also sought to reduce provisions that allow companies to shift income and investment outside the U.S. while giving tax credits to American companies to bring operations back.

    "In the absence of comprehensive reform, you can still

  • News Breaks
    May 12, 2014
    07:17 EDT QCOR, MNK Questcor downgraded to Neutral from Overweight at Piper Jaffray
    Piper Jaffray downgraded Questcor (QCOR) to Neutral saying the investigations into the company are unlikely to derail the takeover by Mallinckrodt (MNK). Piper lowered its price target for shares to $96 from $98.

    Sentiment: Strong Buy

  • News Breaks
    May 12, 2014
    08:15 EDT HLT Hilton upgraded to Buy from Neutral at UBS
    UBS upgraded Hilton Worldwide to Buy citing peer outperformance and catalysts from two new brands this year. The firm raised its price target for shares to $26 from $23.

    Sentiment: Strong Buy

  • another big win for BX....

    Sentiment: Strong Buy

  • Reply to

    Hilton profit-nearly-quadruples

    by crzace May 9, 2014 8:57 AM
    sam_0534 sam_0534 May 9, 2014 12:12 PM Flag

    BX is the best company in its group and the stock price is not reflecting this now;; getting hit with the spec and traders selling and it is so foolish...stocastics very oversold..good buy here...I dont think HLT is in the S&P 500 since it is new..will get a boost when it gets in..which it will...
    Hilton Worldwide (HLT) - The international hotelier surprised investors to the upside this week. First-quarter profits tripled for the world's largest hotel operator, and the company raised its full year profit forecast. Hilton also said it was planning to build new hotels. Shares of Hilton were up as much as 4% this morning.
    Those are you Trending Tickers today. We'll see you back here Monday.

    Sentiment: Strong Buy

  • kets & Finance
    SUBSCRIBE NOW


    Global Economics
    Companies & Industries
    Politics & Policy
    Technology
    Markets & Finance
    Innovation & Design
    Lifestyle
    Business Schools
    Small Business
    Video & Multimedia

    Finance
    Three Signs the Best Days of Private Equity Are Over
    By Sheelah Kolhatkar May 08, 2014

    Lest the buyout industry feel left out of the regulatory crackdown that has recently been visited upon hedge funds and major banks, the Securities and Exchange Commission indicated it’s taking a close look at the fees and compliance structures at private equity funds. The SEC found “illegal fees or severe compliance shortfalls in more than half of the firms it examined since starting a review of the $3.5 trillion industry two years ago,” Drew Bowden, the head of the SEC’s exam program, said in a speech on Tuesday. More scrutiny is sure to come.

    Like hedge funds, private equity funds have historically been lightly regulated because their investors were ostensibly rich folk who, by virtue of the sophistication wealth naturally confers, require less protection and could better sustain losses. PE funds, also like hedge funds, typically charge 1.5 percent to 2 percent of assets as a management fee and keep 15 percent to 20 percent of the profits they generate. And, like hedge funds, private equity funds have seen an increasing proportion of their investment capital coming from investors who aren’t sophisticated at all, in the form of pension funds and endowments that manage money for ordinary people.

    The 2010 Dodd-Frank legislation gave the SEC greater leeway to regulate private equity firms, and in 2012 the agency created a special unit to look into the industry. The bits of information that have trickled out about the SEC’s findings so far haven’t reflected well on private equity: Most funds were inflating the fees they were charging the companies they’d invested in, Bloomberg News reported on April 7. They’ve also been applying fees to investors that the firms themselves should have been paying.

  • Reply to

    BX 200 dma is 27.79 on this chart service...

    by sam_0534 May 8, 2014 11:47 AM
    sam_0534 sam_0534 May 8, 2014 11:48 AM Flag

    stocastics giving major buy

    Sentiment: Strong Buy

BX
34.19-0.15(-0.44%)Jul 29 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.